Short-term outcome of endoscopic submucosal dissection using a clutch cutter for subepithelial lesions within the esophagogastric submucosa: a Japanese prospective observational study.

Clutch cutter Endosonography Esophagus Stomach Subepithelial lesion

Journal

Clinical endoscopy
ISSN: 2234-2400
Titre abrégé: Clin Endosc
Pays: Korea (South)
ID NLM: 101576886

Informations de publication

Date de publication:
10 Oct 2024
Historique:
received: 21 04 2024
accepted: 10 06 2024
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 10 10 2024
Statut: aheadofprint

Résumé

The efficacy and safety of endoscopic submucosal dissection using a clutch cutter (ESD-CC) for subepithelial lesions within the esophagogastric submucosa (SELEGSM) has not been investigated. This study aimed to assess the efficacy and safety of ESD-CC for the treatment of SELEGSM. This prospective study included 15 consecutive patients with 18 SELEGSMs diagnosed by endoscopic ultrasonography. The primary outcomes were short-term outcomes including en bloc resection rate, R0 resection rate, procedure time, and complication rate. The secondary outcome was final histological diagnosis. Among the participants, 18 lesions were identified: 12 in the stomach (nine patients) and six in the esophagus (six patients). The en bloc resection rate was 94.4% (17/18). The R0 resection rate was 88.9% (16/18). The median operating time was 39 min, and no instances of perforation or bleeding were observed. The final diagnoses of SELEGSM included six neuroendocrine tumors (33.3%), six granular cell tumors (33.3%), two ectopic pancreases (11.1%), one inflammatory fibroid polyp (5.6%), one leiomyoma (5.6%), one lipoma (5.6%), and one leiomyosarcoma (5.6%). ESD-CC appears to be a technically efficient and safe approach for SELEGSM resection, suggesting its potential as a valuable treatment option.

Sections du résumé

Background/Aims UNASSIGNED
The efficacy and safety of endoscopic submucosal dissection using a clutch cutter (ESD-CC) for subepithelial lesions within the esophagogastric submucosa (SELEGSM) has not been investigated. This study aimed to assess the efficacy and safety of ESD-CC for the treatment of SELEGSM.
Methods UNASSIGNED
This prospective study included 15 consecutive patients with 18 SELEGSMs diagnosed by endoscopic ultrasonography. The primary outcomes were short-term outcomes including en bloc resection rate, R0 resection rate, procedure time, and complication rate. The secondary outcome was final histological diagnosis.
Results UNASSIGNED
Among the participants, 18 lesions were identified: 12 in the stomach (nine patients) and six in the esophagus (six patients). The en bloc resection rate was 94.4% (17/18). The R0 resection rate was 88.9% (16/18). The median operating time was 39 min, and no instances of perforation or bleeding were observed. The final diagnoses of SELEGSM included six neuroendocrine tumors (33.3%), six granular cell tumors (33.3%), two ectopic pancreases (11.1%), one inflammatory fibroid polyp (5.6%), one leiomyoma (5.6%), one lipoma (5.6%), and one leiomyosarcoma (5.6%).
Conclusions UNASSIGNED
ESD-CC appears to be a technically efficient and safe approach for SELEGSM resection, suggesting its potential as a valuable treatment option.

Identifiants

pubmed: 39385518
pii: ce.2024.094
doi: 10.5946/ce.2024.094
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Kazuya Akahoshi (K)

Endoscopy Center, Aso Iizuka Hospital, Iizuka, Japan.

Kazuki Inamura (K)

Department of Gastroenterology, Aso Iizuka Hospital, Iizuka, Japan.

Kazuaki Akahoshi (K)

Endoscopy Center, Aso Iizuka Hospital, Iizuka, Japan.

Shigeki Osada (S)

Department of Gastroenterology, Aso Iizuka Hospital, Iizuka, Japan.

Shinichi Tamura (S)

Endoscopy Center, Aso Iizuka Hospital, Iizuka, Japan.

Yoshihiro Oishi (Y)

Department of Pathology, Aso Iizuka Hospital, Iizuka, Japan.

Masafumi Oya (M)

Department of Pathology, Aso Iizuka Hospital, Iizuka, Japan.

Hidenobu Koga (H)

Clinical Research Support Office, Aso Iizuka Hospital, Iizuka, Japan.

Classifications MeSH